MEMPHASYS LIMITED. — Board/Management Information 2009

Jul 1, 2009

==> picture [173 x 57] intentionally omitted <==

FOR IMMEDIATE RELEASE

Appointment of a New Director

– SYDNEY, AUSTRALIA – 2[nd] July 2009 NuSep (ASX: NSP) wishes to advise the market that Mr William Spee has joined the NuSep Board of Directors.

Mr Spee joins the Board at a time when the Company has achieved profitability in its Gels Division. Mr W Spee brings a wealth of entrepreneurial and financial experience to the NuSep Board.

Mr Spee has had over 30 years business experience including naval aviation, computers, electronics manufacturing and small scale retail. He currently runs a successful commercial property investment business. Mr Spee has dealt extensively with major banks and financiers. He has a number of investments in the share market, and is particularly interested in biotech and life science sector.

“I believe NuSep has a very bright future, particularly in the Proteomic and IVF areas”, said Mr Spee. “NuSep’s products address markets which has enormous potential over the coming years”, he added.

“I welcome Bill to the Board. He brings a broad range of business skills and understanding of the Biotechnology industry. He will be an important addition to the Board”, said Mr John Manusu, Executive Chairman of NuSep.

About NuSep

NuSep (ASX: NSP) is a publicly listed life sciences company that sells products into the global bioseparations market. The company has offices in both Sydney, Australia and Atlanta, USA.

With a 30 year heritage in biological separations, NuSep has forged a world class reputation for its innovative yet simple biological separation techniques including the world’s first IVF sperm separation device. In short NuSep has redefined the BioSeparations market through innovation and simplification.

NuSep’s world renowned research team has developed an extensive portfolio of patented products. In all, NuSep currently manufactures, distributes and sells 55 products to customers in the USA, Europe, Asia and Australia.

NuSep Products:

==> picture [13 x 10] intentionally omitted <==

==> picture [13 x 10] intentionally omitted <==

• Gels – NuSep manufactures and sells precast gels including the innovative iGels, with a 2 year shelf life.

Separation Instruments – NuSep has developed two unique biological separation instruments. The first instrument released in 2008 can separate biological samples into 8

NuSep Ltd 324 Burns Bay Rd Lane Cove NSW 2066	Postal Address P.O. Box 823 Lane Cove NSW 1595	Contact Details Telephone +61 2 8977 9000 Facsimile +61 2 8977 9099	Emailinfo@nusep.com Webwww.nusep.com ABN33 120 047 556

– 2 –

==> picture [13 x 10] intentionally omitted <==

fractions for use in the proteomic market. The second instrument separates sperm for fertility treatments such as IVF and is presently undergoing clinical trials. Biological Products – NuSep supplies research grade biological products manufactured using its unique separation technologies. These products include human IgG and Albumin.

For more information about NuSep please visit the company’s website www.NuSep.com

Contact: Prakash Patel Chief Financial Officer & Company Secretary +61 2 8977 9000 prakash.patel@nusep.com